PRICE T ROWE ASSOCIATES INC /MD/ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$478
+19.5%
159,290
-1.9%
0.00%
Q2 2023$400
-1.0%
162,436
-9.0%
0.00%
Q1 2023$404
-38.2%
178,440
-4.8%
0.00%
Q4 2022$654
-100.0%
187,459
-4.6%
0.00%
-100.0%
Q3 2022$7,278,000
+127.1%
196,556
+16.5%
0.00%
Q2 2022$3,205,000
-24.6%
168,757
+7.1%
0.00%
Q1 2022$4,253,000
+1915.6%
157,565
+1855.6%
0.00%
Q3 2021$211,000
-95.8%
8,057
-93.8%
0.00%
-100.0%
Q4 2019$5,049,000129,4610.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders